07:00 , Aug 15, 2013 |  BC Innovations  |  Translation in Brief

Translational tidbits

Scripps' Sigma factor Academic and industry researchers eager to use new tool compounds typically must reproduce synthetic schemes published in academic journals or wait months for reagent makers to list new compounds in their catalogs....
07:00 , Jul 15, 2013 |  BC Week In Review  |  Company News

BioNTech, immatics cancer news

The Glioma Actively Personalized Vaccine Consortium (GAPVAC) received €6 million ($7.8 million) in funding from the EU's Framework Programme 7 (FP7) to develop a new class of therapeutic cancer vaccines for brain cancer patients. The...